{"id":"NCT00450112","sponsor":"Seikagaku Corporation","briefTitle":"Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee","officialTitle":"A Multi-Center Extension and Open-Label Study of a Single or Repeat Intra-Articular Injection of Gel-200 in Osteoarthritis of the Knee.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2007-03-21","resultsPosted":"2011-08-22","lastUpdate":"2011-08-22"},"enrollment":202,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis of the Knee"],"interventions":[{"type":"DEVICE","name":"Gel-200","otherNames":[]}],"arms":[],"summary":"The purpose of this study is to determine if a single or repeat intra-articular injection of Gel-200 is safe and effective in subjects with symptomatic osteoarthritis of the knee and to determine if original SI-6606/01 Gel-200 therapy is durable beyond the original study.","primaryOutcome":{"measure":"Occurrence of Systemic and Local Adverse Events Following a Single or Repeat Intra-articular Injection of Gel-200","timeFrame":"13 weeks","effectByArm":[{"arm":"2Gel-200","deltaMin":68,"sd":null},{"arm":"1PBS1Gel-200","deltaMin":43,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":">0.1"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29780263","27250845"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":125},"commonTop":["Joint effusion","Joint swelling","Arthralgia"]}}